Literature DB >> 33743228

Gene therapy for spinal muscular atrophy: hope and caution.

Nathalie Goemans1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33743228     DOI: 10.1016/S1474-4422(21)00071-5

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  3 in total

Review 1.  Advances in gene therapy for neurogenetic diseases: a brief review.

Authors:  Ying-Xuan Xie; Wen-Qi Lv; Yi-Kun Chen; Shunyan Hong; Xiang-Ping Yao; Wan-Jin Chen; Miao Zhao
Journal:  J Mol Med (Berl)       Date:  2021-11-27       Impact factor: 4.599

Review 2.  Onasemnogene Abeparvovec: A Review in Spinal Muscular Atrophy.

Authors:  Hannah A Blair
Journal:  CNS Drugs       Date:  2022-08-12       Impact factor: 6.497

Review 3.  Precision Medicine Based on CFTR Genotype for People with Cystic Fibrosis.

Authors:  Iram Haq; Maryam Almulhem; Simone Soars; David Poulton; Malcolm Brodlie
Journal:  Pharmgenomics Pers Med       Date:  2022-02-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.